Clinical Trial Update: Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity [Phase 4]

View source ↗

Summary

A Phase 4 comparative trial evaluating sitagliptin versus gliclazide with metformin in patients with type 2 diabetes and glucotoxicity; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucotoxicity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Gliclazide (gliclazide)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Zhibin Xu | Conditions: Type 2 Diabetes Mellitus, Glucotoxicity | Phase 4 | Status: COMPLETED